Inicio / Noticias de Biosimilares / Biosimilars in Europe: 11…

Biosimilars in Europe: 11 years, 28 approvals, 0 safety concerns

0 / 5 (0 votos)
Biosimilars in Europe: 11 years, 28 approvals, 0 safety concerns

The EMA has not experienced any concerns with the safety of the 28 biosimilar products it has recommended, according to an information guide published for healthcare professionals.

The guide – written in collaboration with the European Commission and published below – aims to provide healthcare professionals with information on the science and regulation underpinning the use of biosimilars and was launched at a stakeholder conference on biosimilar medicines in Brussels last week.

SEGUIR LEYENDO

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.